| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Richard C. Oude Voshaar | Q67415121 |
| Ulrich Eisel | Q40741711 | ||
| P2093 | author name string | Robert A Schoevers | |
| Hans C Klein | |||
| Anatoliy V Gladkevich | |||
| Fokko J Bosker | |||
| Eric G Ruhé | |||
| Erin M Van Buel | |||
| Mike C Jentsch | |||
| P2860 | cites work | The Kraepelinian dichotomy - going, going... but still not gone | Q22241683 |
| The catecholamine hypothesis of affective disorders: a review of supporting evidence | Q22306296 | ||
| Monoamine oxidase: from genes to behavior | Q24614980 | ||
| Cytokines sing the blues: inflammation and the pathogenesis of depression | Q24633065 | ||
| From inflammation to sickness and depression: when the immune system subjugates the brain | Q24633527 | ||
| The subgenual anterior cingulate cortex in mood disorders | Q24649017 | ||
| Abnormal amygdala-prefrontal effective connectivity to happy faces differentiates bipolar from major depression. | Q37340244 | ||
| Computational biology for cardiovascular biomarker discovery | Q37411833 | ||
| Molecular tools for assessing human depression by positron emission tomography | Q37510244 | ||
| Investigating serotonergic function using positron emission tomography: overview and recent findings | Q37724994 | ||
| Cytokines mediated inflammation and decreased neurogenesis in animal models of depression | Q37769871 | ||
| Epigenetics and depression: current challenges and new therapeutic options. | Q37774224 | ||
| The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research? | Q37775892 | ||
| Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders | Q37778476 | ||
| A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities | Q37799100 | ||
| Animal models of depression and anxiety: What do they tell us about human condition? | Q37815580 | ||
| Discovering imaging endophenotypes for major depression | Q37878247 | ||
| Neuroimaging markers of cellular function in major depressive disorder: implications for therapeutics, personalized medicine, and prevention | Q37973223 | ||
| Microglia as modulators of cognition and neuropsychiatric disorders | Q38022207 | ||
| Neurochemical imaging and depressive behaviours | Q38047252 | ||
| Is altered BDNF biosynthesis a general feature in patients with cognitive dysfunctions? | Q38067671 | ||
| Steroid hormones and BDNF. | Q38079070 | ||
| The search for peripheral disease markers in psychiatry by genomic and proteomic approaches | Q38089247 | ||
| EEG biomarkers in major depressive disorder: discriminative power and prediction of treatment response | Q38154919 | ||
| DNA methylation and epigenetic mechanisms | Q38206837 | ||
| Age-associated decrease in serum glial cell line-derived neurotrophic factor levels in patients with major depressive disorder | Q39269170 | ||
| Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression | Q39532426 | ||
| Glial cell-line derived neurotrophic factor (GDNF) concentrations in cerebrospinal fluid and serum of patients with early Alzheimer's disease and normal controls | Q39827741 | ||
| Serotonin transporter binding with [123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender | Q40006155 | ||
| Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients | Q40014805 | ||
| Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity | Q40036871 | ||
| Evidence for an immune response in major depression: a review and hypothesis | Q40501767 | ||
| Shared ligands and receptors as a molecular mechanism for communication between the immune and neuroendocrine systems | Q40572387 | ||
| Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications | Q24649095 | ||
| Cytokine, sickness behavior, and depression | Q24657818 | ||
| Neuroreceptor imaging in depression | Q26865008 | ||
| Neurogenesis, inflammation and behavior | Q27016122 | ||
| Epigenetic programming by maternal behavior | Q27860466 | ||
| Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene | Q27860482 | ||
| Altered expression of neurotrophic factors in patients with major depression | Q28271088 | ||
| Serotonin-1A receptors in major depression quantified using PET: controversies, confounds, and recommendations | Q28731687 | ||
| A neurotrophic model for stress-related mood disorders | Q29616291 | ||
| Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression | Q29617326 | ||
| Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients | Q30468799 | ||
| A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder | Q30486593 | ||
| Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients | Q30511886 | ||
| Factors underlying variable DNA methylation in a human community cohort | Q30525742 | ||
| Emotional valence modulates brain functional abnormalities in depression: evidence from a meta-analysis of fMRI studies. | Q30579956 | ||
| Data-driven subtypes of major depressive disorder: a systematic review | Q30580130 | ||
| Hippocampal volume and depression: a meta-analysis of MRI studies | Q30974294 | ||
| Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections | Q30977897 | ||
| Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes. | Q33241006 | ||
| A new perspective on transcriptional system regulation (TSR): towards TSR profiling. | Q33320982 | ||
| "Omics" data and levels of evidence for biomarker discovery | Q33362789 | ||
| Acid hydrolysis followed by matrix-assisted laser desorption/ionization mass spectrometry for the rapid diagnosis of serum protein biomarkers in patients with major depression | Q33402521 | ||
| Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression | Q33492323 | ||
| Poor replication of candidate genes for major depressive disorder using genome-wide association data | Q33547331 | ||
| Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users | Q33620656 | ||
| Immune correlates of depression. | Q33708102 | ||
| Epigenetics: regulation through repression | Q33751823 | ||
| Depressive illness | Q33759114 | ||
| Gene expression studies in major depression. | Q33762208 | ||
| Elevated amygdala activity to sad facial expressions: a state marker of bipolar but not unipolar depression | Q33787034 | ||
| Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review | Q33867444 | ||
| A molecular signature of depression in the amygdala | Q33899136 | ||
| In vivo monitoring of adult neurogenesis in health and disease. | Q33908325 | ||
| Cross-national epidemiology of DSM-IV major depressive episode | Q33971969 | ||
| Glucocorticoids and depression | Q33974278 | ||
| The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute | Q34025130 | ||
| The corticosteroid receptor hypothesis of depression | Q34057906 | ||
| Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression | Q34084102 | ||
| Integrating neurobiological markers of depression. | Q34153576 | ||
| Animal models of depression: molecular perspectives | Q34158534 | ||
| 5-HT radioligands for human brain imaging with PET and SPECT | Q34192729 | ||
| The default mode network and recurrent depression: a neurobiological model of cognitive risk factors | Q34262696 | ||
| The immune system, depression and the action of antidepressants | Q34268481 | ||
| Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis | Q34309013 | ||
| Imaging treatment effects in depression | Q34323653 | ||
| Depression: a case of neuronal life and death? | Q34335476 | ||
| Hippocampal synaptic dysregulation of exo/endocytosis-associated proteins induced in a chronic mild-stressed rat model | Q34393535 | ||
| MRI findings in patients with affective disorder: a meta-analysis | Q34439133 | ||
| Frontocingulate dysfunction in depression: toward biomarkers of treatment response | Q34565649 | ||
| Depression pathogenesis and treatment: what can we learn from blood mRNA expression? | Q34577617 | ||
| Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states | Q34580335 | ||
| Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies | Q34612909 | ||
| Biomarkers in the age of omics: time for a systems biology approach | Q34692190 | ||
| Meta-analyses of genetic studies on major depressive disorder | Q34701323 | ||
| 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB. | Q34721207 | ||
| The validity of animal models of predisposition to depression | Q34745257 | ||
| Proteomics reveals energy and glutathione metabolic dysregulation in the prefrontal cortex of a rat model of depression | Q34751775 | ||
| Principle component analysis combined with matrix-assisted laser desorption ionization mass spectrometry for rapid diagnosing the sera of patients with major depression | Q34777555 | ||
| A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression | Q34815480 | ||
| Neural correlates of dysfunctional emotion regulation in major depressive disorder. A systematic review of neuroimaging studies | Q34911585 | ||
| Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis | Q35085459 | ||
| Neurobiology of emotion perception II: Implications for major psychiatric disorders | Q35208704 | ||
| How does the social environment 'get into the mind'? Epigenetics at the intersection of social and psychiatric epidemiology. | Q35633967 | ||
| PET imaging of beta-adrenoceptors in human brain: a realistic goal or a mirage? | Q35768650 | ||
| Plasma biomarkers of depressive symptoms in older adults | Q35844316 | ||
| Association of depressive disorders, depression characteristics and antidepressant medication with inflammation | Q35844355 | ||
| Brain plasticity and antidepressant treatments: new cells, new connections | Q36003816 | ||
| Cytokines and major depression | Q36031971 | ||
| Major depressive disorder: new clinical, neurobiological, and treatment perspectives | Q36096664 | ||
| The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: a meta-analysis | Q36110161 | ||
| Imaging the dopamine system with in vivo [11C]raclopride displacement studies: understanding the true mechanism | Q36136737 | ||
| Depression and cortisol responses to psychological stress: a meta-analysis | Q36165619 | ||
| VEGF is a chemoattractant for FGF-2-stimulated neural progenitors | Q36324941 | ||
| Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function | Q36377477 | ||
| Glucocorticoids, cytokines and brain abnormalities in depression | Q36442019 | ||
| Identification and validation of urinary metabolite biomarkers for major depressive disorder | Q36508139 | ||
| Neural substrates of increased memory sensitivity for negative stimuli in major depression | Q36776052 | ||
| The epigenetic basis of twin discordance in age-related diseases | Q36783169 | ||
| Targeting neurotrophic/growth factor expression and signaling for antidepressant drug development | Q36789610 | ||
| Modelling the molecular mechanisms of synaptic plasticity using systems biology approaches | Q36796537 | ||
| Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus | Q36837563 | ||
| Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression | Q36848923 | ||
| Amygdala activity and prefrontal cortex-amygdala effective connectivity to emerging emotional faces distinguish remitted and depressed mood states in bipolar disorder | Q36989045 | ||
| Inflammation: a new candidate in modulating adult neurogenesis | Q37024273 | ||
| Neurobiological mechanisms in major depressive disorder | Q37071342 | ||
| Gene expression profiling in postmortem prefrontal cortex of major depressive disorder | Q37148356 | ||
| Radiolabeled glucocorticoids as molecular probes for imaging brain glucocorticoid receptors by means of positron emission tomography (PET). | Q37185298 | ||
| Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB. | Q37261294 | ||
| Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo | Q37280609 | ||
| The association between immune activation and manic symptoms in patients with a depressive disorder. | Q37281155 | ||
| Depression, stress and immunological activation: the role of cytokines in depressive disorders | Q41705538 | ||
| Interleukin-6 and tumor necrosis factor-alpha production after acute psychological stress, exercise, and infused isoproterenol: differential effects and pathways | Q41756546 | ||
| Serum brain-derived neurotrophic factor levels in different neurological diseases. | Q41811172 | ||
| [11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: a comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitis | Q41863477 | ||
| Imaging endogenous dopamine competition with [11C]raclopride in the human brain | Q42496463 | ||
| Distribution volume ratio of serotonin and dopamine transporters in euthymic patients with a history of major depression - a dual-isotope SPECT study | Q42844380 | ||
| In vivo imaging of neuroinflammation: a comparative study between [(18)F]PBR111, [ (11)C]CLINME and [ (11)C]PK11195 in an acute rodent model | Q43196007 | ||
| Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence | Q43227363 | ||
| Peripheral vascular endothelial growth factor level is associated with antidepressant treatment response: results of a preliminary study | Q43419566 | ||
| Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research | Q43789984 | ||
| Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA). | Q43890291 | ||
| Gender-related urocortin 1 and brain-derived neurotrophic factor expression in the adult human midbrain of suicide victims with major depression | Q43949314 | ||
| Diagnostic accuracy of serum brain derived neurotrophic factor concentration in antidepressant naïve patients with first major depression episode | Q44516139 | ||
| Methylomics in psychiatry: Modulation of gene-environment interactions may be through DNA methylation | Q44860138 | ||
| Dopamine transmission in the human striatum during monetary reward tasks. | Q44872444 | ||
| Preferential 5-HT1A autoreceptor occupancy by pindolol is attenuated in depressed patients: effect of treatment or an endophenotype of depression? | Q44883665 | ||
| [11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease? | Q45090570 | ||
| Neutrophil gelatinase-associated lipocalin: a novel inflammatory marker associated with late-life depression. | Q45723807 | ||
| Altered expression of lipid metabolism and immune response genes in the frontal cortex of suicide completers | Q45750341 | ||
| A new animal model of (chronic) depression induced by repeated and intermittent lipopolysaccharide administration for 4 months | Q45799497 | ||
| Depression gene. Back to the drawing board for psychiatric genetics. | Q45952474 | ||
| Machine learning classification with confidence: application of transductive conformal predictors to MRI-based diagnostic and prognostic markers in depression. | Q45962941 | ||
| Mediodorsal thalamic lesions block the stress-induced inversion of serial memory retrieval pattern in mice. | Q45999474 | ||
| Synthesis and preliminary evaluation of [(18)F]-fluoro-(2S)-Exaprolol for imaging cerebral beta-adrenergic receptors with PET. | Q46448913 | ||
| Whole-exome sequencing identifies a polymorphism in the BMP5 gene associated with SSRI treatment response in major depression. | Q47830777 | ||
| Neurobiology of serotonin in depression and suicide | Q48003233 | ||
| Identification of a 5-HT1 recognition site in human brain membranes different from 5-HT1A, 5-HT1B and 5-HT1C sites | Q48100231 | ||
| Increased levels of serum basic fibroblast growth factor in schizophrenia. | Q48171439 | ||
| Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. | Q48261354 | ||
| Pathophysiology of hypercortisolism in depression | Q48284356 | ||
| Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. | Q48369669 | ||
| Pituitary volume in treatment-naïve pediatric major depressive disorder. | Q48459893 | ||
| Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder. | Q48464800 | ||
| Evaluating the comparability of gene expression in blood and brain. | Q48623627 | ||
| Serotonin-1A receptor binding is positively associated with gray matter volume -- a multimodal neuroimaging study combining PET and structural MRI. | Q48637684 | ||
| Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation. | Q48658510 | ||
| Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study. | Q48787872 | ||
| Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients. | Q48871364 | ||
| Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders. | Q48936946 | ||
| Regulation of cytoskeleton machinery, neurogenesis and energy metabolism pathways in a rat gene-environment model of depression revealed by proteomic analysis. | Q48937629 | ||
| Plasma levels of vascular endothelial growth factor and fibroblast growth factor 2 in patients with major depressive disorders. | Q49094544 | ||
| Altered systemic cortisol metabolism in bipolar disorder and schizophrenia spectrum disorders. | Q50659392 | ||
| Decreased serum levels of the angiogenic factors VEGF and TGF-β1 in Alzheimer's disease and amnestic mild cognitive impairment. | Q50857992 | ||
| Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. | Q51039593 | ||
| Meta-analysis of the association between the monoamine oxidase-A gene and mood disorders. | Q51597854 | ||
| Angiogenic factors in patients with current major depressive disorder comorbid with borderline personality disorder. | Q51670433 | ||
| Pre-treatment EEG and it's relationship to depression severity and paroxetine treatment outcome. | Q53899331 | ||
| Stimulated gene expression profiles as a blood marker of major depressive disorder. | Q54428030 | ||
| Major Depressive Disorder | Q56016676 | ||
| The monocyte-T-lymphocyte hypothesis of major depression | Q56767511 | ||
| P433 | issue | 3 | |
| P921 | main subject | hypothesis | Q41719 |
| biomarker | Q864574 | ||
| major depressive disorder | Q42844 | ||
| P304 | page(s) | 277-297 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Biomarkers in Medicine | Q20313333 |
| P1476 | title | Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses | |
| P478 | volume | 9 |
| Q90796877 | Affect fluctuations examined with ecological momentary assessment in patients with current or remitted depression and anxiety disorders |
| Q89964600 | Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients |
| Q59329380 | Automatic detection of major depressive disorder using electrodermal activity |
| Q47671635 | Biomarkers for Major Depressive Disorder: Economic Considerations |
| Q33710918 | Circuits Regulating Pleasure and Happiness in Bipolar Disorder |
| Q57029714 | Cortical Excitability and Activation of TrkB Signaling During Rebound Slow Oscillations Are Critical for Rapid Antidepressant Responses |
| Q91691179 | Entropy analysis of heart rate variability and its application to recognize major depressive disorder: A pilot study |
| Q42369081 | From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder |
| Q46605766 | Inherent vulnerabilities in monoaminergic pathways predict the emergence of depressive impairments in an animal model of chronic epilepsy. |
| Q58765626 | N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial |
| Q98163665 | Novel candidate genes for ECT response prediction-a pilot study analyzing the DNA methylome of depressed patients receiving electroconvulsive therapy |
| Q92757782 | Persistent depressive symptoms, HPA-axis hyperactivity, and inflammation: the role of cognitive-affective and somatic symptoms |
| Q90285737 | Psychopharmacology: From serendipitous discoveries to rationale design, but what next? |
| Q64322365 | The evolutionary old forebrain as site of action to develop new psychotropic drugs |
| Q38604950 | Translational Identification of Transcriptional Signatures of Major Depression and Antidepressant Response. |
| Q90669053 | Weighted Gene Coexpression Network Analysis Identifies Specific Modules and Hub Genes Related to Major Depression |
Search more.